US 9663575
CD47 antibodies and methods of use thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9663575 (CD47 antibodies and methods of use thereof) held by Inhibrx, Inc. expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K39/39558, A61K45/06